Straberi Epistamp Device for Postinflammatory Hyperpigmentation

Completed · Not applicable

Conditions studied: Postinflammatory Hyperpigmentation

In brief

This pilot study will expand knowledge and application needling using the Straberi device for the improvement of Postinflammatory Hyperpigmentation (PIH) caused by acne.

Key facts

Study ID
NCT04740255
Run by
Universal Skincare Institute
People needed
30
Starts
2022-12-23
Expected to finish
2023-10-12
Last updated by the study team
2023-12-06

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.